title: Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
authors.affiliation: University Hospital Dijkzigt, Rotterdam.
authors.forename: T A
authors.initials: TA
authors.lastname: Splinter
authors.forename: F J
authors.initials: FJ
authors.lastname: ten Kate
authors.forename: F H
authors.initials: FH
authors.lastname: Schröder
authors.forename: L
authors.initials: L
authors.lastname: Denis
authors.forename: D
authors.initials: D
authors.lastname: Newling
authors.forename: W G
authors.initials: WG
authors.lastname: Jones
authors.forename: D
authors.initials: D
authors.lastname: Jacqmin
authors.forename: C G
authors.initials: CG
authors.lastname: Boeken Kruger
authors.forename: G
authors.initials: G
authors.lastname: Stoter
authors.forename: H J
authors.initials: HJ
authors.lastname: de Voogt
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011300:Preoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D002945:Cisplatin; D008727:Methotrexate